UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044661
Receipt number R000050655
Scientific Title Clinical implication of body mass index in patients undergoing cardiac revascularization for acute myocardial infarction: Comparison of ST-elevation and non-ST-elevation myocardial infarction
Date of disclosure of the study information 2021/06/25
Last modified on 2024/06/27 09:33:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical implication of body mass index in patients with acute myocardial infarction

Acronym

Clinical implication of body mass index in patients with acute myocardial infarction

Scientific Title

Clinical implication of body mass index in patients undergoing cardiac revascularization for acute myocardial infarction: Comparison of ST-elevation and non-ST-elevation myocardial infarction

Scientific Title:Acronym

Clinical implication of body mass index in patients undergoing cardiac revascularization for acute myocardial infarction: Comparison of ST-elevation and non-ST-elevation myocardial infarction

Region

Japan


Condition

Condition

Acute myocardial infarction

Classification by specialty

Cardiology Geriatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Despite smaller infarct size and lower rate of coronary occlusion, worse prognosis is shown in patients with NSTEMI compared to those with STEMI. This is because geriatric condition may be strongly associated with long-term prognosis rather than cardiac damage. The aim of this study is to investigate the prognostic difference of body mass index in patients with ST- and non-ST-elevation myocardial infarction.

Basic objectives2

Others

Basic objectives -Others

Clinical implication of muscle wasting calculated by height, weight, age, and gender in patients with acute myocardial infarction

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Major adverse cardiovascular events including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke

Key secondary outcomes

All-cause death


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients hospitalized with acute myocardial infarction
2) Patients undergoing coronary angiography
3) Patients undergoing revascularization including percutaneous coronary intervention or coronary artery bypass graft during hospitalization

Key exclusion criteria

1) Patients with out-of-hospital cardiac arrest
2) Lacking of height and body weight on admission in medical record

Target sample size

1200


Research contact person

Name of lead principal investigator

1st name Koichiro
Middle name
Last name Matsumura

Organization

Kindai University

Division name

Department of Cardiology

Zip code

5898511

Address

377-2, Ohnohigashi, Osakasayama

TEL

+81723660221

Email

kmatsumura1980@yahoo.co.jp


Public contact

Name of contact person

1st name Koichiro
Middle name
Last name Matsumura

Organization

Kindai University

Division name

Department of Cardiology

Zip code

5898511

Address

377-2, Ohnohigashi, Osakasayama

TEL

+81723660221

Homepage URL


Email

kmatsumura1980@yahoo.co.jp


Sponsor or person

Institute

Kindai University

Institute

Department

Personal name



Funding Source

Organization

Kindai University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kenichi Fujii, Department of Cardiology, Kansai Medical University
Hiroshi Matsumoto, Department of Cardiology, Kansai Medical University Medical Center

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kindai University

Address

377-2, Ohnohigashi, Osakasayama

Tel

+81723660221

Email

kmatsumura1980@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

近畿大学病院(大阪府大阪狭山市)、関西医科大学附属病院(大阪府枚方市)、関西医科大学総合医療センター(大阪府守口市)


Other administrative information

Date of disclosure of the study information

2021 Year 06 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2021 Year 02 Month 01 Day

Date of IRB

2017 Year 02 Month 07 Day

Anticipated trial start date

2021 Year 02 Month 01 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Retrospective observational study
Patient prognosis was obtained by medical record or sending questionnaire to follow-up hospital
Appendicular skeletal muscle mass was estimated according to height, body weight, age and gender using an anthropometric equation previously validated in Asian populations
Muscle wasting was defined as skeletal muscle index (appendicular skeletal muscle mass(kg)/height(m)/height(m))<7.0kg/m2 in men and <5.4kg/m2 in women according to AWGS guideline 2019


Management information

Registered date

2021 Year 06 Month 25 Day

Last modified on

2024 Year 06 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050655